Kringle Pharma, Inc. (TYO:4884)
Japan flag Japan · Delayed Price · Currency is JPY
501.00
-73.00 (-12.72%)
Nov 18, 2026, 10:39 AM JST

Kringle Pharma Revenue

In the fiscal year ending September 30, 2026, Kringle Pharma had annual revenue of 442.00M JPY with 513.89% growth. Kringle Pharma had revenue of 118.11M in the quarter ending September 30, 2026, with 552.30% growth. That makes Kringle Pharma the 41,691st largest company in the world by revenue and 3,848th in Japan.

Revenue
442.00M
Revenue Growth
+513.89%
P/S Ratio
10.89
Revenue / Employee
n/a
Employees
17
Market Cap
4.20B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 2026442.00M370.00M513.89%
Sep 30, 202572.00M-8.00M-10.00%
Sep 30, 202480.00M11.00M15.94%
Sep 30, 202369.00M-322.00M-82.35%
Sep 30, 2022391.00M102.00M35.29%
Sep 30, 2021 Pro Pro Pro
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.